Shunten International (Holdings) Ltd. 0932

McCormick (NYSE: MKC) removed Ernst & Young as its independent auditor following independence concerns tied to the planned Unilever Foods deal. The company appointed KPMG as its new external auditor to oversee financial reporting after the anticipated Unilever Foods transaction. Ernst & Young had served as McCormick's long term audit firm before being replaced in connection with the Unilever Foods integration plan. The auditor switch linked to the Unilever Foods transaction should not be the...

Clene (NASDAQ:CLNN) said it plans to submit a new drug application to the U.S. Food and Drug Administration at the beginning of the fourth quarter for CNM-Au8, its investigational treatment for amyotrophic lateral sclerosis, or ALS. In a fireside chat at the Lytham Partners Fall 2026 Investor Confe

LONDON, October 02, 2026-- FORM 8.3

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION (a)Full name of discloser:Dimensional Fund Advisors Ltd. whose parent is Dimensional Fund Advisors LP, and also on behalf their investment advisory affiliates (“Dimensional”). The Dimensional entities are investment advisors and Dimensional expressly disclaims beneficial ownership of the shares describe

Vancouver, British Columbia--(Newsfile Corp. - October 2, 2026) - Adaptogenics Health Corp. (CSE: ADPT) ("Adaptogenics" or the "Company") is pleased to announce the appointment of J. David Warren, Ph.D., as Chief Executive Officer and as a director of the Company, effective October 1st, 2026.Dr. Warren brings more than two decades of experience in bioorganic chemistry, medicinal chemistry, peptide science and translational drug discovery. He is an Adjunct Associate Professor of Research in...

McCormick (MKC) just reaffirmed its full year outlook, projecting net sales growth of 13% to 17% for fiscal 2026, after reporting mixed third quarter results and continuing integration work on recent deals. Recent trading tells a different story to the upbeat guidance. McCormick’s share price has fallen 18.65% over the past 30 days and is down 34.39% year to date, while the 1 year total shareholder return has declined 33.08%. This suggests momentum has weakened as investors reassess execution...

Consumers are ill at ease as retailers increase prices based on their shopping history or income.

The changes reflect new views on restaurant demand, retail traffic, travel growth, drug risks and competition in financial data.

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason, and a low valuation can reflect underlying business challenges rather than a genuine bargain.

If you own Amazon stock, your worry is probably the bill for data centers and AI. On its July 30, 2026 call, management put Amazon's capital spending for 2026 at about $220 billion. The stock has returned 13.1% over the past twelve months, less than the S&P 500's 16.0%. Here are the events most likely to move Amazon stock over the next six months, starting with late October's earnings reports.

Hershey (HSY) just announced a leadership change in its international arm, naming Amanda Almond as President, International. The appointment puts fresh attention on how the business approaches markets outside the U.S. That appointment comes at a time when Hershey’s share price has slipped. The 30-day share price return is down 9.49% and the year-to-date share price return is down 12.67%, while the 1-year total shareholder return has declined 13.18% and the 5-year total shareholder return is...